ReviewFrontiers in psychiatry2026
From risk to resilience: a narrative overview of modifiable factors influencing depression in children with autism spectrum disorder (part I).
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition frequently associated with internalizing disorders, particularly depression, which significantly impacts functioning and quality of life (QoL) in children and adolescents. Objective: This paper represents the first part of a two-part structured narrative overview examining internalizing psychopathology in children and adolescents with ASD. Given the high co-occurrence and shared neurobiological, psychological, and environmental mechanisms linking depression and anxiety, the multidisciplinary research team elected to develop two complementary overviews to allow a more comprehensive and clinically meaningful synthesis of the evidence. The present review specifically aims to identify and synthesize current evidence on modifiable risk and protective factors influencing depression in children and adolescents with ASD. Methods: A structured narrative overview was conducted, integrating evidence from systematic reviews, meta-analyses, and robust clinical studies. Studies were selected based on relevance and methodological quality, and findings were synthesized across biological, psychosocial, and lifestyle domains. Results: Growing body of evidence indicates that depression in ASD is influenced by a complex interplay of genetic vulnerability, sensory and emotional dysregulation, social stressors, and environmental factors. At the same time, modifiable protective factors-including physical activity, psychosocial interventions, digital health approaches, and family-centered care-show potential in enhancing resilience and emotional well-being. However, the evidence base remains heterogeneous and often limited by methodological constraints. Conclusions: A multidisciplinary and prevention-oriented approach that simultaneously addresses risk and strengthens protective pathways may optimize mental health outcomes and improve QoL in children and adolescents with ASD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.